Strata Critical Medical, Inc.

NASDAQ:SRTA

Airlines, Airports & Air Services

Industrials
$4.96 -0.43%

-$0.03 today

Market cap
$443.03M
Beta
2.20
P/E (TTM)
9.7
EPS (TTM)
$0.60
52W Low $3.57High $6.50

Volume 0.99M

Average 0.91M

SRTA Selling, General & Admin

Overhead costs of running the business, including sales, marketing, management, and administrative staff.

Strata Critical Medical, Inc.NASDAQ: SRTA

Selling, General & Admin · Q1 FY2026 · quarter ended Mar 2026

Selling, general & admin declines year over year

Q1 FY2026 selling, general & admin of $13.21M fell 29.5% year over year, in line with the -29.1% change in trailing-twelve-month selling, general & admin. Sequentially, it rose 16.3% from the prior quarter. Over 3 fiscal years it compounded at -13.7% a year.

Context

  • Selling, general & admin amounted to 22.9% of revenue in FY2025, down 13.2 pp from a year earlier.
  • Selling, general & admin increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether selling, general & admin reaches the consensus estimate from 3 analysts of $131.68M (+192.1%) for the fiscal year ending Dec 2026, a step up from the -49.7% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
$13.21M+16.3% QoQ
Last fiscal yearDec 2025
$45.08M-49.7% YoY
LTMMar 2026
$63.13M-29.1% YoY
Selling, General & Admin past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-29.5%+41.0%+70.6 pp
1 year-49.7%+192.1%+241.8 pp
3-year CAGR-13.7%+53.4%+67.1 pp
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Selling, General & Admin history

USD · from the income statement

Latest · FY2025
45.08M USD
Year-over-year change
-49.7%
4-year CAGR
+8.2%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Selling, General & Admin vs competitors

How SRTA compares with its peers on the latest reported figures

  • Peers report in different currencies, so selling, general & admin is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -29.1% is the lowest of 10, against a peer median of +0.2%.
  • Selling, general & admin amounts to 24.8% of revenue for SRTA, versus a peer median of 17.3%.
SRTA Competitors
Selling, General & Admin for SRTA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
KFRCKforce Inc.LTM Mar 2026$307.34M USD+0.2%-7.0%23.1%
ZIPZipRecruiter, Inc.LTM Mar 2026$289.7M USD-0.4%-20.7%64.9%
CYRXCryoport, Inc.LTM Mar 2026$108.54M USD-14.0%+1.8%59.3%
ORNOrion Group Holdings, Inc.LTM Mar 2026$97.25M USD+13.0%+14.4%11.1%
ULHUniversal Logistics Holdings, Inc.LTM Apr 2026$78.72M USD+4.2%-20.9%5.1%
AIROAIRO Group Holdings, Inc. Common StockLTM Mar 2026$71.73M USD+194.1%+44.1%81.5%
EBFEnnis, Inc.LTM Feb 2026$67.79M USD+3.7%—17.3%
EVTLVertical Aerospace Ltd.LTM Mar 2026£67.48M GBP—-0.8%—
MTRXMatrix Service CompanyLTM Mar 2026$64.24M USD-9.4%+1.7%7.6%
FLYXflyExclusive, Inc.LTM Mar 2026$64.01M USD-4.7%+15.4%16.7%
SRTAStrata Critical Medical, Inc.LTM Mar 2026$63.13M USD-29.1%-13.7%24.8%
Peer median (excluding SRTA) —+0.2%+1.7%17.3%

Competitors are the stored peer set for SRTA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Sep 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue50.53M146.12M225.18M248.69M197.14M
Cost of Revenue40.01M123.85M183.06M189.77M158.82M
Gross Profit10.52M22.28M42.12M58.92M38.33M
Gross Margin20.8%15.2%18.7%23.7%19.4%
Research & Development1.68M5.55M4.63M3.18M3.05M
Selling, General & Admin32.93M70.26M105.61M89.66M45.08M
Operating Expenses34.61M75.8M110.24M92.85M48.13M
Depreciation & Amortization596K5.73M7.11M5.96M6.9M
EBITDA(43.1M)(22.31M)(50.43M)(21.6M)(13.17M)
EBITDA Margin-85.3%-15.3%-22.4%-8.7%-6.7%
Operating Income(24.09M)(53.53M)(68.12M)(33.93M)(9.81M)
Operating Margin-47.7%-36.6%-30.3%-13.6%-5.0%
Interest Income460K3.43M8.44M7.21M4.24M
Interest Expense00000
Other Income / Expenses(19.6M)25.5M10.58M6.36M(10.26M)
Income Before Tax(43.7M)(28.03M)(57.54M)(27.56M)(20.07M)
Pre-Tax Margin-86.5%-19.2%-25.6%-11.1%-10.2%
Income Tax Expense(3.64M)(772K)(1.47M)(255K)0
Net Income(40.05M)(27.26M)(56.08M)(27.31M)(15.65M)
Net Margin-79.3%-18.7%-24.9%-11.0%-7.9%
EPS (Basic)(0.57)(0.38)(0.76)(0.35)(0.19)
EPS (Diluted)(0.57)(0.38)(0.76)(0.35)(0.19)
Weighted Avg Shares70.1M71.24M73.52M77.5M82.45M
Weighted Avg Shares (Diluted)70.1M71.24M73.52M77.5M82.45M

Strata Critical Medical, Inc.

NASDAQ:SRTA

Intrinsic Alpha fair value

Locked

Current Price

$4.96

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.